Naga Surekha et al, Solid Lipid Nanoparticles As Carriers Of Natural Phenolic Compounds., Indo Am. J. P. Sci, 2023; 10 (03).

1. Billot, J. Evolution des composes phénoliques au cours de la maturation de la Poire Passe-Crassane.
Physiol. Vég. 1983, 21. [CrossRef]
2. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability.
Am. J. Clin. Nutr. 2004, 79, 727–747. [CrossRef] [PubMed]
3. Cordova, A.C.; Sumpio, B.E. Polyphenols are medicine: Is it time to prescribe red wine for our patients?
Int. J. Angiol. 2009, 18, 111–117. [CrossRef] [PubMed]
4. Lamy, S.; Beaulieu, É.; Labbé, D.P.; Bédard, V.; Moghrabi, A.; Barrette, S.; Gingras, D.; Béliveau, R. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008, 29, 1033–1041. [CrossRef] [PubMed]
5. Shipp, J.; Abdel-Aal, E.-S. Food Applications and physiological effects of anthocyanins as functional food ingredients. Open Food Sci. J. 2010, 4, 7–22. [CrossRef]
6. Lesschaeve, I.; Noble, A.C. Polyphenols: Factors influencing their sensory properties and their effects on food and beverage preferences. Am. J. Clin. Nutr. 2005, 81, 330S–335S. [CrossRef]
7. Nunes, S.; Madureira, R.; Campos, D.A.; Sarmento, B.; Gomes, A.M.; Pintado, M.; Reis, F.; Madureira, A.R.; Pintado, M.M. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications. Crit. Rev. Food Sci. Nutr. 2017, 57, 1863–1873. [CrossRef]
8. McDougall, G.J.; Stewart, D. The inhibitory effects of berry polyphenols on digestive enzymes. Biofactors
2005, 23, 189–195. [CrossRef]
9. Fernandes, I.; Pérez-Gregorio, R.; Soares, S.; Mateus, N.; De Freitas, V. Wine flavonoids in health and disease prevention. Molecules 2017, 22, 292. [CrossRef]
10. Faridi Esfanjani, A.; Assadpour, E.; Jafari, S.M. Improving the bioavailability of phenolic compounds by loading them within lipid-based nanocarriers. Trends Food Sci. Technol. 2018, 76, 56–66. [CrossRef]
11. Mehnert, W.; Mäder, K. Solid lipid nanoparticles: Production, characterization and applications.
Adv. Drug Deliv. Rev. 2012, 64, 83–101. [CrossRef]
12. Higdon, J.V.; Frei, B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions.
Crit. Rev. Food Sci. Nutr. 2003, 43, 89–143. [CrossRef]
13. Crespy, V.; Williamson, G. A review of the health effects of green tea catechins in in vivo animal models.
J. Nutr. 2004, 134, 3431S–3440S. [CrossRef] [PubMed]
14. Sloley, B.D.; Urichuk, L.J.; Morley, P.; Durkin, J.; Shan, J.J.; Pang, P.K.T.; Coutts, R.T. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo Biloba leaves.
J. Pharm. Pharmacol. 2000, 52, 451–459. [CrossRef]
15. Salehi, B.; Venditti, A.; Cho, W.C.S.; Kre˛giel, D.; Cho, W.C.S.; Durazzo, A.; Lucarini, M.; Santini, A.; Santini, A.; Novellino, E.; et al. The therapeutic potential of apigenin. Int. J. Mol. Sci. 2019, 20, 1305. [CrossRef] [PubMed]
16. Lesjak, M.; Beara, I.; Simin, N.; Pintac´, D.; Majkic´, T.; Bekvalac, K.; Orcˇic´, D.; Mimica-Dukic, N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods 2018, 40, 68–75. [CrossRef]
17. Dajas, F. Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012,
143, 383–396. [CrossRef]
18. Omenn, G.S. What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart disease? Ann. Epidemiol. 1995, 5, 333–335. [CrossRef]
19. Fernandes, I.; Faria, A.; Azevedo, J.; Soares, S.; Calhau, C.; De Freitas, V.; Mateus, N. Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation.
J. Agric. Food Chem. 2010, 58, 3785–3792. [CrossRef]
20. Ikram, M.; Muhammad, T.; Rehman, S.U.; Khan, A.; Jo, M.G.; Ali, T.; Kim, M.O. Hesperetin confers neuroprotection by regulating Nrf2/TLR4/NF-κB signaling in an Aβ mouse model. Mol. Neurobiol. 2019, 56, 6293–6309. [CrossRef]
21. Song, T.T.; Hendrich, S.; Murphy, P.A. Estrogenic activity of glycitein, a soy isoflavone. J. Agric. Food Chem.
1999, 47, 1607–1610. [CrossRef]
22. Bensaad, L.A.; Kim, K.H.; Quah, C.C.; Kim, W.R.; Shahimi, M. Anti-inflammatory potential of ellagic acid, gallic acid and punicalagin A&B isolated from Punica granatum. BMC Complementary Altern. Med. 2017, 17, 47.
23. Lima, V.N.; Oliveira-Tintino, C.D.; Santos, E.S.; Morais, L.P.; Tintino, S.R.; Freitas, T.S.; Geraldo, Y.S.; Pereira, R.L.; Cruz, R.P.; Menezes, I.R.; et al. Antimicrobial and enhancement of the antibiotic activity by phenolic compounds: Gallic acid, caffeic acid and pyrogallol. Microb. Pathog. 2016, 99, 56–61. [CrossRef]
24. Ndiaye, M.; Philippe, C.; Mukhtar, H.; Ahmad, N. The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges. Arch. Biochem. Biophys. 2011, 508, 164–170. [CrossRef]
25. Figueiredo, P.; Lintinen, K.; Kiriazis, A.; Hynninen, V.; Liu, Z.; Bauleth-Ramos, T.; Rahikkala, A.; Correia, A.; Kohout, T.; Sarmento, B.; et al. In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells. Biomaterials 2017, 121, 97–108. [CrossRef]
26. Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery—A review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50, 161–177. [CrossRef]
27. Lucks, J.S.; Muller, R.H. Medication Vehicles Made of Solid Lipid Nanoparticles (Solid Lipid Nanospheres). WO Patent No. EP0000605497, 18 September 1991.
28. Han, S.B.; Kwon, S.S.; Jeong, Y.M.; Yu, E.R.; Park, S.N. Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin. Int. J. Cosmet. Sci. 2014, 36, 588–597. [CrossRef]
29. Reis, S.; Neves, A.R.; Lúcio, M.; Martins, S.; Lima, J.L.C. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomed. 2013, 8, 177–187. [CrossRef]
30. Gregoriadis, G. (Ed.) Liposome Techonology; CRC Press Inc.: Boca Raton, FL, USA, 1984.
31. Gregoriadis, G.; Florence, A.T.; Patel, H.M. (Eds.) Liposomes in Drug Delivery; Harwood Academic Publishers: Amsterdam, The Netherlands, 1993.
32. Pimentel-Moral, S.; Teixeira, M.C.; Fernandes, A.R.; Arráez-Román, D.; Martínez-Férez, A.; Segura-Carretero, A.; Souto, E.B. Lipid nanocarriers for the loading of polyphenols—A comprehensive review. Adv. Colloid Interface Sci. 2018, 260, 85–94. [CrossRef] [PubMed]
33. Simonazzi, A.; Cid, A.G.; Villegas, M.; Romero, A.I.; Palma, S.D.; Bermúdez, J.M. Chapter 3-Nanotechnology applications in drug controlled release. In Drug Targeting and Stimuli Sensitive Drug Delivery Systems; Grumezescu, A.M., Ed.; William Andrew Publishing: Norwich, NY, USA, 2018; pp. 81–116.
34. Livney, Y.D. Nanostructured delivery systems in food: Latest developments and potential future directions.
Curr. Opin. Food Sci. 2015, 3, 125–135. [CrossRef]
35. Wretlind, A. Development of fat emulsions. JPEN J. Parenter. Enteral. Nutr. 1981, 5, 230–235. [CrossRef]
36. Lu, W.; Kelly, A.L.; Miao, S. Emulsion-based encapsulation and delivery systems for polyphenols. Trends Food Sci. Technol. 2016, 47, 1–9. [CrossRef]
37. Pardeike, J.; Hommoss, A.; Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009, 366, 170–184. [CrossRef]
38. Silva, A.M.; Martins-Gomes, C.; Fangueiro, J.F.; Andreani, T.; Souto, E.B. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines. Pharm. Dev. Technol. 2019, 24, 1243–1249. [CrossRef]
39. Kondel, R.; Shafiq, N.; Kaur, I.P.; Singh, M.P.; Pandey, A.K.; Ratho, R.K.; Malhotra, S. Effect of acyclovir solid lipid nanoparticles for the treatment of Herpes Simplex Virus (HSV) infection in an animal model of HSV-1 infection. Pharm. Nanotechnol. 2019, 7, 389–403. [CrossRef]
40. Esposito, E.; Sguizzato, M.; Drechsler, M.; Mariani, P.; Carducci, F.; Nastruzzi, C.; Valacchi, G.; Cortesi, R. Lipid nanostructures for antioxidant delivery: A comparative preformulation study. Beilstein J. Nanotechnol. 2019, 10, 1789–1801. [CrossRef] [PubMed]
41. Da Silva Santos, V.; Ribeiro, A.P.B.; Santana, M.H.A. Solid lipid nanoparticles as carriers for lipophilic compounds for applications in foods. Food Res. Int. 2019, 122, 610–626. [CrossRef] [PubMed]
42. Ban, C.; Jo, M.; Park, Y.H.; Kim, J.H.; Han, J.Y.; Lee, K.W.; Kweon, D.-H.; Choi, Y.J. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Food Chem. 2020, 302, 125328. [CrossRef] [PubMed]
43. Campos, J.R.; Severino, P.; Santini, A.; Silva, A.M.; Shegokar, R.; Souto, S.B.; Souto, E.B. Chapter 1-Solid lipid nanoparticles (SLN): Prediction of toxicity, metabolism, fate and physicochemical properties. In Nanopharmaceuticals; Shegokar, R., Ed.; Elsevier: Amsterdam, The Netherlands, 2020; pp. 1–15.
44. Zhai, Y.; Zhai, G. Advances in lipid-based colloid systems as drug carrier for topic delivery. J. Control. Release
2014, 193, 90–99. [CrossRef]
45. Schwarz, C.; Mehnert, W.; Lucks, J.; Müller, R. Solid lipid nanoparticles (SLN) for controlled drug delivery.
I. Production, characterization and sterilization. J. Control. Release 1994, 30, 83–96. [CrossRef]
46. Eiras, F.; Amaral, M.H.; Silva, R.; Martins, E.; Lobo, J.M.S.; Silva, A. Characterization and biocompatibility evaluation of cutaneous formulations containing lipid nanoparticles. Int. J. Pharm. 2017, 519, 373–380. [CrossRef]
47. Li, H.; Zhao, X.; Ma, Y.; Zhai, G.; Li, L.; Lou, H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Release 2009, 133, 238–244. [CrossRef]
48. Tsai, M.-J.; Wu, P.-C.; Huang, Y.-B.; Chang, J.-S.; Lin, C.-L.; Tsai, Y.-H.; Fang, J.-Y. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int. J. Pharm. 2012, 423, 461–470. [CrossRef]
49. Tsai, M.-J.; Huang, Y.-B.; Wu, P.-C.; Fu, Y.-S.; Kao, Y.-R.; Fang, J.-Y.; Tsai, Y.-H. Oral apomorphine delivery from solid lipid nanoparticles with different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations. J. Pharm. Sci. 2011, 100, 547–557. [CrossRef]
50. Li, J.; Guo, X.; Liu, Z.; Okeke, C.I.; Li, N.; Zhao, H.; Aggrey, M.O.; Pan, W.; Wu, T. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: Pharmacokinetics, cytotoxicity and cellular uptake studies. Drug Dev. Ind. Pharm. 2014, 40, 980–987. [CrossRef]
51. Zhou, W.; Xie, S.; Zhu, L.; Dong, Z.; Wang, Y.; Wang, X. Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles. Int. J. Nanomed. 2011, 6, 547–555. [CrossRef]
52. Puglia, C.; Frasca, G.; Musumeci, T.; Rizza, L.; Puglisi, G.; Bonina, F.; Chiechio, S. Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice. Eur. J. Pharm. Biopharm. 2012, 81, 288–293. [CrossRef]
53. Lin, Y.-K.; Huang, Z.-R.; Zhuo, R.-Z.; Fang, J.-Y. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomed. 2010, 5, 117–128.
54. Yang, X.-Y.; Li, Y.-X.; Li, M.; Zhang, L.; Feng, L.-X.; Zhang, N. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett. 2013, 334, 338–345. [CrossRef] [PubMed]
55. Navarro, F.P.; Creusat, G.; Frochot, C.; Moussaron, A.; Verhille, M.; Vanderesse, R.; Thomann, J.-S.; Boisseau, P.; Texier, I.; Couffin, A.-C.; et al. Preparation and characterization of mTHPC-loaded solid lipid nanoparticles for photodynamic therapy. J. Photochem. Photobiol. B Biol. 2014, 130, 161–169. [CrossRef] [PubMed]
56. Carbone, C.; Teixeira, M.D.C.; Sousa, M.D.C.; Martins-Gomes, C.; Silva, A.M.; Souto, E.B.; Musumeci, T. Clotrimazole-loaded mediterranean essential oils NLC: A synergic treatment of Candida skin infections. Pharmaceutics 2019, 11, 231. [CrossRef] [PubMed]
57. Müller, R.H.; Shegokar, R.; Keck, C.M. 20 years of lipid nanoparticles (SLN and NLC): Present state of development and industrial applications. Curr. Drug Discov. Technol. 2011, 8, 207–227. [CrossRef] [PubMed]
58. Souto, E.B.; Almeida, A.; Müller, R.H. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery:
Structure, protection and skin effects. J. Biomed. Nanotechnol. 2007, 3, 317–331. [CrossRef]
59. Souto, E.B.; Wissing, S.A.; Barbosa, C.M.; Müller, R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278, 71–77. [CrossRef]
60. Ganesan, P.; Narayanasamy, D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain. Chem. Pharm. 2017, 6, 37–56. [CrossRef]
61. Jenning, V.; Schäfer-Korting, M.; Gohla, S. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control. Release 2000, 66, 115–126. [CrossRef]
62. Fang, Z.; Bhandari, B. Encapsulation of polyphenols—A review. Trends Food Sci. Technol. 2010,
21, 510–523. [CrossRef]
63. Munin, A.; Edwards-Lévy, F. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics
2011, 3, 793–829. [CrossRef]
64. Da Silva, S.B.; Ferreira, D.; Pintado, M.; Sarmento, B. Chitosan-based nanoparticles for rosmarinic acid ocular delivery—In vitro tests. Int. J. Biol. Macromol. 2016, 84, 112–120. [CrossRef]
65. Campos, D.A.; Madureira, A.R.; Sarmento, B.; Pintado, M.M.; Gomes, A.M. Technological stability of solid lipid nanoparticles loaded with phenolic compounds: Drying process and stability along storage. J. Food Eng. 2017, 196, 1–10. [CrossRef]
66. Trombino, S.; Cassano, R.; Muzzalupo, R.; Pingitore, A.; Cione, E.; Picci, N. Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of β-carotene and α-tocopherol. Colloids Surf. B Biointerfaces 2009, 72, 181–187. [CrossRef]
67. Barras, A.; Mezzetti, A.; Richard, A.; Lazzaroni, S.; Roux, S.; Melnyk, P.; Betbeder, D.; Monfilliette-Dupont, N. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int. J. Pharm. 2009, 379, 270–277. [CrossRef] [PubMed]
68. Shishikura, Y.; Khokhar, S.; Murray, B.S. Effects of tea polyphenols on emulsification of olive oil in a small intestine model system. J. Agric. Food Chem. 2006, 54, 1906–1913. [CrossRef]
69. Doktorovova, S.; Souto, E.B.; Silva, A.M. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers—A systematic review of in vitro data. Eur. J. Pharm. Biopharm. 2014, 87, 1–18. [CrossRef] [PubMed]
70. Freitas, C.; Müller, R.H. Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte. J. Microencapsul. 1999, 16, 59–71. [CrossRef]
71. Erni, C.; Suard, C.; Freitas, S.; Dreher, N.; Merkle, H.P.; Walter, E. Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials 2003, 23, 4667–4676. [CrossRef]
72. Shtay, R.; Keppler, J.K.; Schrader, K.; Schwarz, K. Encapsulation of (–)-epigallocatechin-3-gallate (EGCG) in solid lipid nanoparticles for food applications. J. Food Eng. 2019, 244, 91–100. [CrossRef]
73. Trombino, S.; Cassano, R.; Ferrarelli, T.; Barone, E.; Picci, N.; Mancuso, C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B Biointerfaces 2013, 109, 273–279. [CrossRef]
74. Cassano, R.; Trombino, S.; Muzzalupo, R.; Tavano, L.; Picci, N. A novel dextran hydrogel linking trans-ferulic acid for the stabilization and transdermal delivery of vitamin E. Eur. J. Pharm. Biopharm. 2009, 72, 232–238. [CrossRef]
75. Trombino, S.; Cassano, R.; Bloise, E.; Muzzalupo, R.; Tavano, L.; Picci, N. Synthesis and antioxidant activity evaluation of a novel cellulose hydrogel containing trans-ferulic acid. Carbohydr. Polym. 2009, 75, 184–188. [CrossRef]
76. Huang, J.; Wang, Q.; Li, T.; Xia, N.; Xia, Q. Nanostructured lipid carrier (NLC) as a strategy for encapsulation of quercetin and linseed oil: Preparation and in vitro characterization studies. J. Food Eng. 2017, 215, 1–12. [CrossRef]
77. Lander, R.; Manger, W.; Scouloudis, M.; Ku, A.; Davis, C.; Lee, A. Gaulin homogenization: A mechanistic study.
Biotechnol. Prog. 2000, 16, 80–85. [CrossRef] [PubMed]
78. Jorgensen, L.; Nielson, H.M. (Eds.) Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines; John Wiley & Sons Ltd.: Chichester, UK, 2009.
79. Muller, R.; Runge, S.; Ravelli, V.; Mehnert, W.; Thunemann, A.; Souto, E. Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int. J. Pharm. 2006, 317, 82–89. [CrossRef]
80. Almeida, A.J.; Runge, S.; Müller, R.H. Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters. Int. J. Pharm. 1997, 149, 255–265. [CrossRef]
81. Santonocito, D.; Sarpietro, M.G.; Carbone, C.; Panico, A.; Campisi, A.; Siciliano, E.A.; Sposito, G.; Castelli, F.; Puglia, C. Curcumin containing PEGylated solid lipid nanoparticles for systemic administration: A preliminary study. Molecules 2020, 25, 2991. [CrossRef]
82. Sjöström, B.; Bergenståhl, B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 1992, 88, 53–62. [CrossRef]
83. Picone, P.; Bondì, M.L.; Montana, G.; Bruno, A.; Pitarresi, G.; Giammona, G.; Di Carlo, M. Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles. Free Radic. Res. 2009, 43, 1133–1145. [CrossRef] [PubMed]
84. Nayak, A.P.; Tiyaboonchai, W.; Patankar, S.; Madhusudhan, B.; Souto, E.B. Curcuminoids-loaded lipid nanoparticles: Novel approach towards malaria treatment. Colloids Surf. B Biointerfaces 2010, 81, 263–273. [CrossRef] [PubMed]
85. Pandita, D.; Kumar, S.; Poonia, N.; Lather, V. Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol. Food Res. Int. 2014, 62, 1165–1174. [CrossRef]
86. Trotta, M.; Debernardi, F.; Caputo, O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int. J. Pharm. 2003, 257, 153–160. [CrossRef]
87. Schubert, M.A.; Müller-Goymann, C.C. Solvent injection as a new approach for manufacturing lipid nanoparticles—Evaluation of the method and process parameters. Eur. J. Pharm. Biopharm. 2003, 55, 125–131. [CrossRef]
88. Ferreira, M.; Chaves, L.L.; Lima, S.A.C.; Reis, S. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy. Int. J. Pharm. 2015, 492, 65–72. [CrossRef] [PubMed]
89. Yang, R.; Gao, R.; Li, F.; He, H.; Tang, X. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev. Ind. Pharm. 2011, 37, 139–148. [CrossRef] [PubMed]
90. Pimentel-Moral, S.; Teixeira, M.; Fernandes, A.; Borrás-Linares, I.; Arráez-Román, D.; Martínez-Férez, A.; Segura-Carretero, A.; Souto, E.B. Polyphenols-enriched Hibiscus sabdariffa extract-loaded nanostructured lipid carriers (NLC): Optimization by multi-response surface methodology. J. Drug Deliv. Sci. Technol. 2019, 49, 660–667. [CrossRef]
91. Ravanfar, R.; Tamaddon, A.M.; Niakousari, M.; Moein, M.R. Preservation of anthocyanins in solid lipid nanoparticles: Optimization of a microemulsion dilution method using the Placket–Burman and Box–Behnken designs. Food Chem. 2016, 199, 573–580. [CrossRef]
92. Bunjes, H.; Siekmann, B.; Westesen, K. Chapter 7-Emulsions of supercooled melts—A novel drug delivery system. In Submicron Emulsions in Drug Targeting and Delivery; Benita, S., Ed.; Harwood Academic Publishers: Amsterdam, The Netherlands, 1998; pp. 175–218.
93. Weyhers, H.; Mehnert, W.; Hahn, H.; Müller, R.H. Solid lipid nanoparticles-determination of in vivo toxicity. In Proceedings of the 1st World Meeting on Pharmaceutics. Biopharmaceutics, Pharmaceutical Technology, Budapest, Hungary, 9–11 May 1995.
94. Jenning, V.; Gysler, A.; Schäfer-Korting, M.; Gohla, S.H. Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 2000, 49, 211–218. [CrossRef]
95. Freitas, C.; Müller, R.H. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and
crystallinity of the lipid phase. Eur. J. Pharm. Biopharm. 1999, 47, 125–132. [CrossRef]
96. Müller, R.H.; Heinemann, S. Fat emulsions for parenteral nutrition. III: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load. Int. J. Pharm. 1994, 101, 175–189. [CrossRef]
97. Huang, C.-C.; Wu, P.-C.; Tsai, T.-H.; Fang, Y.-P.; Tsai, Y.-H.; Cheng, T.-C.; Huang, M.-Y.; Chen, F.-M.; Hsieh, Y.-C.; Lin, W.-W.; et al. Development of pH-sensitive cationic PEGylated solid lipid nanoparticles for selective cancer-targeted therapy. J. Biomed. Nanotechnol. 2017, 13, 192–203.
98. Pardeshi, C.; Rajput, P.; Belgamwar, V.; Tekade, A.; Patil, G.; Chaudhary, K.; Sonje, A. Solid lipid based nanocarriers: An overview. Acta Pharm. 2012, 62, 433–472. [CrossRef] [PubMed]
99. Chou, L.Y.; Ming, K.; Chan, W.C. Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev.
2011, 40, 233–245. [CrossRef] [PubMed]
100. Hans, M.L.; Lowman, A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci. 2002, 6, 319–327. [CrossRef]
101. Gaspar, D.; Almeida, A. Surface-functionalized lipid nanoparticles for site-specific drug delivery. In Surface Modification of Nanoparticles for Targeted Drug Delivery; Pathak, Y.V., Ed.; Springer: Cham, Switzerland, 2019; pp. 73–98.
102. Saha, K.; Bajaj, A.; Duncan, B.; Rotello, V.M. Beauty is skin deep: A surface monolayer perspective on nanoparticle interactions with cells and bio-macromolecules. Small 2011, 7, 1903–1918. [CrossRef] [PubMed]
103. Mout, R.; Moyano, D.F.; Rana, S.; Rotello, V.M. Surface functionalization of nanoparticles for nanomedicine.
Chem. Soc. Rev. 2012, 41, 2539–2544. [CrossRef]
104. Elghanian, R.; Storhoff, J.J.; Mucic, R.C.; Letsinger, R.L.; Mirkin, C.A. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 1997, 277, 1078–1081. [CrossRef]
105. Beloqui, A.; Solinís, M.Á.; Gascón, A.R.; del Pozo-Rodríguez, A.; des Rieux, A.; Préat, V. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J. Control. Release 2013, 166, 115–123. [CrossRef]
106. Mancini, G.; Lopes, R.M.; Clemente, P.; Raposo, S.; Gonçalves, L.M.; Bica, A.; Ribeiro, H.; Almeida, A.J. Lecithin and parabens play a crucial role in tripalmitin-based lipid nanoparticle stabilization throughout moist heat sterilization and freeze-drying: Physical stability of tripalmitin solid lipid nanoparticles. Eur. J. Lipid Sci. Technol. 2015, 117, 1947–1959. [CrossRef]
107. Lim, S.-J.; Kim, C.-K. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm. 2002, 243, 135–146. [CrossRef]
108. Gaspar, D.P.; Faria, V.; Quintas, J.P.; Almeida, A.J.; Gaspar, V.F.D.P. Targeted delivery of lipid nanoparticles by means of surface chemical modification. Curr. Org. Chem. 2017, 21. [CrossRef]
109. Singh, R.; Lillard, J.W. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol. 2009,
86, 215–223. [CrossRef] [PubMed]
110. Cho, K.; Wang, X.U.; Nie, S.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res.
2008, 14, 1310–1316. [CrossRef] [PubMed]
111. Müller, R.H.; Maaben, S.; Weyhers, H.; Mehnert, W. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J. Drug Target. 1996, 4, 161–170. [CrossRef] [PubMed]
112. Xu, X.; Ho, W.; Zhang, X.; Bertrand, N.; Farokhzad, O. Cancer nanomedicine: From targeted delivery to combination therapy. Trends Mol. Med. 2015, 21, 223–232. [CrossRef] [PubMed]
113. Almeida, A.J.; Souto, E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
Adv. Drug Deliv. Rev. 2007, 59, 478–490. [CrossRef]
114. Xu, H.; Deng, Y.-H.; Chen, D.; Hong, W.; Lu, Y.; Dong, X. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J. Control. Release 2008, 130, 238–245. [CrossRef]
115. Loureiro, J.A.; Andrade, S.; Duarte, A.; Neves, A.R.; Queiroz, J.F.; Nunes, C.; Sevin, E.; Fenart, L.; Gosselet, F.; Coelho, M.A.N.; et al. Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s disease. Molecules 2017, 22, 277. [CrossRef]
116. Arranja, A.; Gouveia, L.F.; Gener, P.; Rafael, D.F.; Pereira, C.; Schwartz, S.; Videira, M.A. Self-assembly PEGylation assists SLN-paclitaxel delivery inducing cancer cell apoptosis upon internalization. Int. J. Pharm. 2016, 501, 180–189. [CrossRef]
117. Kraft, J.C.; Freeling, J.P.; Wang, Z.; Ho, R.J.Y. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J. Pharm. Sci. 2014, 103, 29–52. [CrossRef]
118. Byrne, J.D.; Betancourt, T.; Brannon-Peppas, L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 2008, 60, 1615–1626. [CrossRef]
119. Chapman, A.P. PEGylated antibodies and antibody fragments for improved therapy: A review. Adv. Drug Deliv. Rev. 2002, 54, 531–545. [CrossRef]
120. Michaelis, K.; Hoffmann, M.M.; Dreis, S.; Herbert, E.; Alyautdin, R.N.; Kreuter, J.; Langer, K. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J. Pharmacol. Exp. Ther. 2006, 317, 1246–1253. [CrossRef] [PubMed]
121. Neves, A.R.; Queiroz, J.F.; Reis, S. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J. Nanobiotechnol. 2016, 14, 27. [CrossRef]
122. Jose, J.; Netto, G. Role of solid lipid nanoparticles as photoprotective agents in cosmetics. J. Cosmet. Dermatol.
2019, 18, 315–321. [CrossRef] [PubMed]
123. Baek, J.S.; Cho, C.W. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake. Eur. J. Pharm. Biopharm. 2017, 117, 132–140. [CrossRef] [PubMed]
124. Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005, 223, 181–190. [CrossRef] [PubMed]
125. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett. 2008, 267, 133–164. [CrossRef] [PubMed]
126. Shishodia, S.; Chaturvedi, M.M.; Aggarwal, B.B. Role of curcumin in cancer therapy. Curr. Probl. Cancer 2007,
31, 243–305. [CrossRef]
127. Farabegoli, F.; Papi, A.; Orlandi, M. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells. Biosci. Rep. 2011, 31, 99–108. [CrossRef]
128. Santos, I.S.; Ponte, B.M.; Boonme, P.; Silva, A.M.; Souto, E.B. Nanoencapsulation of polyphenols for protective effect against colon–rectal cancer. Biotechnol. Adv. 2013, 31, 514–523. [CrossRef]
129. Radhakrishnan, R.; Kulhari, H.; Pooja, D.; Gudem, S.; Bhargava, S.; Shukla, R.; Ramakrishna, S. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem. Phys. Lipids 2016, 198, 51–60. [CrossRef] [PubMed]
130. Kundu, J.K.; Surh, Y.J. Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett. 2008, 269, 243–261. [CrossRef]
131. Shi, G.; Rao, L.; Yu, H.; Xiang, H.; Yang, H.; Ji, R. Stabilization and encapsulation of photosensitive resveratrol within yeast cell. Int. J. Pharm. 2008, 349, 83–93. [CrossRef] [PubMed]
132. Teskac, K.; Kristl, J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm.
2010, 390, 61–69. [CrossRef] [PubMed]
133. Hu, B.; Liu, X.; Zhang, C.; Zeng, X. Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols. J. Food Drug Anal. 2017, 25, 3–15. [CrossRef]
134. Mori, H.; Kawabata, K.; Yoshimi, N.; Tanaka, T.; Murakami, T.; Okada, T.; Murai, H. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis. Anticancer Res. 1999, 19, 3775–3778.
135. Coradini, K.; Lima, F.; Oliveira, C.; Chaves, P.; Athayde, M.; Carvalho, L.; Beck, R.C.R. Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur. J. Pharm. Biopharm. 2014, 88, 178–185. [CrossRef] [PubMed]
136. Kumar, C.S.; Thangam, R.; Mary, S.A.; Kannan, P.R.; Arun, G.; Madhan, B. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells. Carbohydr. Polym. 2020, 231, 115682. [CrossRef]
137. Granja, A.; Vieira, A.C.; Chaves, L.L.; Nunes, C.; Neves, A.R.; Pinheiro, M.; Reis, S. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate. Food Chem. 2017, 237, 803–810. [CrossRef]
138. Bose, S.; Du, Y.; Takhistov, P.; Michniak, B. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int. J. Pharm. 2013, 441, 56–66. [CrossRef]
139. Casagrande, R.; Georgetti, S.R.; Verri, W.A.; Dorta, D.J.; Dos Santos, A.C.; Fonseca, M.J. Protective effect of topical formulations containing quercetin against UVB-induced oxidative stress in hairless mice. J. Photochem. Photobiol. B Biol. 2006, 84, 21–27. [CrossRef] [PubMed]
140. Plianbangchang, P.; Tungpradit, W.; Tiyaboonchai, W. Efficacy and safety of curcuminoids loaded solid lipid nanoparticles facial cream as an anti-aging agent. Naresuan Univ. J. Sci. Technol. 2013, 15, 73–81.
141. Friedrich, R.B.; Kann, B.; Coradini, K.; Offerhaus, H.L.; Beck, R.C.; Windbergs, M. Skin penetration behavior of lipid-core nanocapsules for simultaneous delivery of resveratrol and curcumin. Eur. J. Pharm. Sci. 2015, 78, 204–213. [CrossRef]
142. Selkoe, D.J. Alzheimer’s disease is a synaptic failure. Science 2002, 298, 789. [CrossRef] [PubMed]
143. Kim, H.-S.; Cho, J.-Y.; Kim, D.H.; Yan, J.-J.; Lee, H.-K.; Suh, H.-W.; Song, D.-K. Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice. Biol. Pharm. Bull. 2004, 27, 120–121. [CrossRef] [PubMed]
144. Bondi, M.; Montana, G.; Craparo, E.; Picone, P.; Capuano, G.; Carlo, M.; Giammona, G. Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimers disease: Preparation, characterization and cytotoxicity studies. Curr. Nanosci. 2009, 5, 26–32. [CrossRef]
145. McClements, D.J. Encapsulation, protection, and release of hydrophilic active components: Potential and limitations of colloidal delivery systems. Adv. Colloid Interface Sci. 2015, 219, 27–53. [CrossRef]
146. Li, X.; Jasti, P.D.B.R. Design of Controlled Release Drug Delivery Systems; McGraw-Hill Education: New York, NY, USA, 2005.
147. Granja, A.; Pinheiro, M.; Reis, S. Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients
2016, 8, 307. [CrossRef]
148. Liang, T.; Guan, R.; Shen, H.; Xia, Q.; Liu, M.-Q. Optimization of conditions for cyanidin-3-O-glucoside (C3G) nanoliposome production by response surface methodology and cellular uptake studies in Caco-2 cells. Molecules 2017, 22, 457. [CrossRef]
149. Desnita, R.; Veronika, M.; Wahdaningsih, S. Topical microemulsion’s formulation of purple sweet potato (Ipomoea batatas L.) ethanol extract as antioxidant by using various concentration of span 80. Int. J. Pharm Tech Res. 2016, 9, 234–239.